Bromopyruvic acid

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Bromopyruvic acid
Skeletal formula of bromopyruvic acid
Ball-and-stick model of the bromopyruvic acid molecule
Preferred IUPAC name
3-Bromo-2-oxopropanoic acid
Other names
3-Bromopyruvic acid
3D model (JSmol)
ECHA InfoCard 100.012.915 Edit this at Wikidata
EC Number
  • 214-206-5
Molar mass 166.958 g·mol−1
Appearance white solid
Melting point 79 to 82 °C (174 to 180 °F; 352 to 355 K) (hydrate)
GHS pictograms GHS05: Corrosive
GHS Signal word Danger
H290, H314, H318
P260, P264, P280, P301+330+331, P303+361+353, P304+340, P305+351+338, P310, P321, P363, P405, P501
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)
Infobox references

Bromopyruvic acid is the organic compound with the formula BrCH2COCO2H. This colorless solid is the brominated derivative of pyruvic acid. It bears structural similarity to lactic acid and pyruvic acid. It has been investigated as a metabolic poison and an anticancer agent.[1] Like other α-bromoketones, it is a strong alkylating agent.


The pyruvate transporter system can be used to deliver bromopyruvate inside trypanosomal cells. Once intracellular, the primary target of 3BP is glyceraldehyde-3-phosphate dehydrogenase, which is highly sensitive to inhibition by bromopyruvate.[2] The pyruvate transporter system, which is known to be overexpressed in cancer cells, was later identified to be a monocarboxylate transporter called monocarboxylate transporter 1.[3]


  1. ^ Peter L. Pedersen (2012). "3-Bromopyruvate (3BP) A Fast Acting, Promising, Powerful, Specific, and Effective "Small Molecule" Anti-Cancer Agent Taken from Labside to Bedside: Introduction to a Special Issue". J. Bioenerg. Biomembr. 44 (1): 1–6. doi:10.1007/s10863-012-9425-4. PMID 22382780.
  2. ^ Barnard, JP; Reynafarje, B; Pedersen, PL (1993). "Glucose catabolism in African trypanosomes. Evidence that the terminal step is catalyzed by a pyruvate transporter capable of facilitating uptake of toxic analogs". The Journal of Biological Chemistry. 268 (5): 3654–3661. PMID 8429041.
  3. ^ Liu, Zhe; Sun, Yiming; Hong, Haiyu; Zhao, Surong; Zou, Xue; Ma, Renqiang; Jiang, Chenchen; Wang, Zhiwei; Li, Huabin (2015-08-15). "3-bromopyruvate enhanced daunorubicin-induced cytotoxicity involved in monocarboxylate transporter 1 in breast cancer cells". American Journal of Cancer Research. 5 (9): 2673–2685. ISSN 2156-6976. PMC 4633897. PMID 26609475.

External links[edit]